Cargando…

Successful autologous stem cell transplantation (ASCT) in a patient with juvenile dermatomyositis

Detalles Bibliográficos
Autores principales:	Holzer, U, Tzaribachev, N, Kuemmerle-Deschner, J, Well, C, Lang, P, Handgretinger, R, Mueller, I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334026/ http://dx.doi.org/10.1186/1546-0096-6-S1-P221

Ejemplares similares

Autologous stem cell transplantation in two children with disabling pansclerotic morphea
por: Moll, M, et al.
Publicado: (2011)

Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
por: Tzaribachev, N, et al.
Publicado: (2008)

Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)
por: Krishnan, A, et al.
Publicado: (2009)

Gastroparesis associated with Juvenile Dermatomyositis
por: Martin, N, et al.
Publicado: (2008)

Respiratory involvement in juvenile dermatomyositis
por: Fabi, M, et al.
Publicado: (2008)

Juvenile dermatomyositis in Western Switzerland
por: Enders, F Bellutti, et al.
Publicado: (2011)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008)

Dyslipidemia in active juvenile dermatomyositis patients
por: Kozu, KT, et al.
Publicado: (2011)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

Subclinical pulmonary abnormalities in juvenile dermatomyositis
por: Sallum, Adriana M, et al.
Publicado: (2014)

The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885)
por: Wittkowski, H, et al.
Publicado: (2008)

Evaluation of the cardiovascular system in patients with juvenile dermatomyositis
por: Opoka – Winiarska, Violetta, et al.
Publicado: (2011)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
por: Clara, Malagón, et al.
Publicado: (2011)

The PRINTO provisional definition of remission in juvenile dermatomyositis
por: Lazarevic, D, et al.
Publicado: (2011)

The role of etanercept in juvenile dermatomyositis (JDMS) in children
por: Green, Katherine L, et al.
Publicado: (2014)

PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report
por: Varnier, GC, et al.
Publicado: (2013)

Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
por: Al-Mansour, Zeina, et al.
Publicado: (2014)

Juvenile dermatomyositis associated to lymphoepithelioma, a nasopharyngeal carcinoma
por: Bica, BERG, et al.
Publicado: (2011)

Juvenile dermatomyositis: clinical and laboratory charateristics of 18 patients
por: Iglesias, E, et al.
Publicado: (2011)

PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
por: Bellutti Enders, F, et al.
Publicado: (2013)

Sleep, fatigue and quality of life in juvenile idiopathic arthritis (JIA) and Juvenile Dermatomyositis (JDM)
por: Avie, Y Butbul, et al.
Publicado: (2008)

8.3 Disease patterns in Danish Juvenile Dermatomyositis patients
por: Mathiesen, PR, et al.
Publicado: (2008)

What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era
por: Smith, S, et al.
Publicado: (2008)

Disease patterns in juvenile dermatomyositis patients from Mumbai, India
por: Khubchandani, RP, et al.
Publicado: (2011)

Tubuloreticular inclusions in juvenile dermatomyositis: a diagnostically useful marker?
por: Yasin, Shireena A, et al.
Publicado: (2014)

Juvenile dermatomyositis in Portuguese children: a case series report
por: Aguiar, Francisca, et al.
Publicado: (2014)

Open label multicenter study of once weekly Etanercept 0.8 mg/kg in active polyarticular Juvenile idiopathic arthritis (JIA)
por: Horneff, G, et al.
Publicado: (2008)

Organ-specific autoantibodies and autoimmune diseases in juvenile systemic lupus erythematosus and juvenile dermatomyositis patients
por: Aikawa, Nadia E, et al.
Publicado: (2012)

COVID 19 Infection in Autologous Stem Cell Transplant (ASCT) Recipients: a Single Institution Observational Cohort
por: Moreb, Jan S., et al.
Publicado: (2023)

Differences in therapeutic approach to juvenile dermatomyositis between Europe and Latin America
por: Trail, L, et al.
Publicado: (2008)

Proposal for the development of an international minimal data collection for juvenile dermatomyositis (JDM)
por: McCann, Liza J, et al.
Publicado: (2011)

Body mass index at diagnosis affects disease course in juvenile dermatomyositis
por: Patwardhan, Anjali, et al.
Publicado: (2012)

PReS-FINAL-2008: Juvenile dermatomyositis: a report of 22 cases
por: Souto, A, et al.
Publicado: (2013)

Regulatory B cell Il-10 production is diminished in juvenile dermatomyositis
por: Piper, Christopher, et al.
Publicado: (2014)

Development and initial validation of a new functional ability tool for juvenile dermatomyositis
por: Varnier, GC, et al.
Publicado: (2011)

Case of juvenile dermatomyositis (JDM), thrombotic thrombocytopenic purpura (TTP), and Purtscher retinopathy
por: Goldzweig, Ofra, et al.
Publicado: (2012)

Prognostic value of histopathologic features with respect to disease course in children with juvenile dermatomyositis
por: Lopez-Martinez, Annette Y, et al.
Publicado: (2012)

PReS-FINAL-2010: Predictive value of whole-body MRI in juvenile dermatomyositis
por: Malattia, C, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_km41jrq1uerkne1auouhs18pc4